A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

Brex, Peter A., Ciccarelli, Olga, O'Riordan, Jonathon I., Sailer, Michael, Thompson, Alan J., Miller, David H.·2002·New England Journal of Medicine
DOI 10.1056/nejmoa011341

Cited by (858)

Items 601–700 of 858

  1. ConfLUNet: Multiple sclerosis lesion instance segmentation in presence of confluent lesions
    Maxence Wynen, Pedro M. Gordaliza, Maxime Istasse, Anna Stölting, Pietro Maggi, Benoit M. M. Macq, Meritxell Bach Cuadra · 2025 · Computers in Biology and Medicine
  2. A proposal: How to study pro-myelinating proteins in MS
    Staley A. Brod · 2021 · Autoimmunity Reviews
  3. Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis
    Simon Arnett, Kerri M. Prain, Sudarshini Ramanathan, Sandeep Bhuta, Fabienne Brilot, Simon Broadley · 2024 · Journal of Neurology
  4. Natural History of Multiple Sclerosis
    Laura E. Baldassari, M. Mateo Paz Soldán · 2021 · Springer eBooks
  5. Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment
    Darrin O. Wijeyaratnam, Thomas A. Edwards, Lara A. Pilutti, Erin Krista Cressman · 2022 · PLoS ONE
  6. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
    Tomáš Kalinčík, Ilya Kister, Tamar E. Bacon, Charles Benjamin Malpas, Sifat Sharmin, Dana Horáková, Eva Havrdová, Francesco Patti, Guillermo Izquierdo, Sara Eichau et al. · 2022 · Multiple Sclerosis Journal
  7. Multiple Sclerosis
    Jack Perry Antel, Amit Bar‐Or · 2004 · Elsevier eBooks
  8. The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse‐onset multiple sclerosis
    Thomas E. Williams, Amanda Heslegrave, Henrik Zetterberg, Katherine Miszkiel, Frederik Barkhof, Olga Ciccarelli, Wallace J. Brownlee, Jeremy Chataway · 2022 · Brain and Behavior
  9. Chapter 6 Optic Neuritis
    Desmond P. Kidd, Gordon Terence Plant · 2008 · Blue books of neurology
  10. L’IRM est-elle utile dans le suivi des patients atteints de sclérose en plaques ? Oui
    Bruno Brochet · 2013 · Revue Neurologique
  11. Qu’attendre des nouvelles techniques IRM dans l’étude de la sclérose en plaques
    Jean Pelletier, Bertrand Audoin, Jean‐Philippe Ranjeva · 2007 · Revue Neurologique
  12. MRI: role in optimising treatment
    Anthony L. Traboulsee · 2004 · Journal of Neurology
  13. FDA-Approved Preventative Therapies for MS: First-line Agents
    Mariko Kita · 2011 · Neurologic Clinics
  14. Magnetic Resonance Imaging Abnormalities in Multiple Sclerosis: A Review
    Sahraeian, Ali Shakouri Rad, Mahmmoud Motamedi, Ernst Wilhelm Radue, Hossein Pakdaman · 2007 · Iranian Journal of Radiology
  15. Elimination Dysfunction in Multiple Sclerosis
    Jodie K. Haselkorn, Michelle A. Stern · 2012
  16. Clinical trial methodology
    Jeffrey A. Cohen, Richard A. Rudick · 2011 · Cambridge University Press eBooks
  17. Clinically Isolated Syndromes
    Nuhad E. Abou Zeid, Sean Joseph Pittock · 2009 · Blue books of neurology
  18. Chapter 10 Magnetic Resonance Imaging and Spectroscopy: Insights into the Pathology and Pathophysiology of Multiple Sclerosis
    Zografos Caramanos, Antônio Carlos dos Santos, Douglas Lorne Arnold · 2003 · Blue books of practical neurology
  19. Functional MRI in multiple sclerosis: a simple motor task gives insights into a complex disease
    Christian Enzinger, Franz Fazekas · 2005 · The Lancet Neurology
  20. Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial.
    Wenjing Luo, Xin Deng, Xiaoyu Xu, Ruitong Song, Meifeng Luo, Heather E. Moss, Yi Du · 2022 · PubMed
  21. Long-term follow-up of suspected though unconfirmed MS
    Nielsen, JM, Uitdehaag, BMJ, Polman, CH · 2008 · Multiple Sclerosis Journal
  22. Factors Affecting Macro-Structural Development in the Cerebral Cortex: The Potential Role of Tissue Removal Through Pruning and Apoptosis
    Jacob E. D. Levman · 2025 · Biology
  23. MRI IN MULTIPLE SCLEROSIS
    Robert A. Bermel, Robert James Fox · 2010 · CONTINUUM Lifelong Learning in Neurology
  24. Blurred vision and pain in the eye
    Michael Harry Barnett, Gurjit Chohan, Leo Davies · 2011 · The Medical Journal of Australia
  25. Role of Neuroimaging in Multiple Sclerosis
    Robert Zivadinov · 2015 · Elsevier eBooks
  26. Neuropathologies underlying acquired language disorders
    Liana S. Rosenthal, Argye Elizabeth Hillis · 2012 · Elsevier eBooks
  27. Multiple Sclerosis: Clinical Features, Immunopathogenesis, and Treatment
    Alexis Lizarraga, William A. Sheremata · 2017 · Springer eBooks
  28. Early predictors of rapidly evolving multiple sclerosis: A case report
    Kryshani Fernando, Michael James · 2017 · Journal of Neuroimmunology
  29. Machine and deep learning in MS research are just powerful statistics – Yes
    Carmen Tur · 2021 · Multiple Sclerosis Journal
  30. MRI features associated with rapid disease activity in clinically isolated syndrome patients at high risk for multiple sclerosis
    Amy De Lury, Joseph Bisulca, Patricia Katherine Coyle, Robert G. Peyster, Lev Bangiyev, Timothy Q. Duong · 2020 · Multiple Sclerosis and Related Disorders
  31. Effects of the Bacillus Calmette-Guérin (BCG) Vaccine in the Demyelinating Disease of the Central Nervous System
    Giovanni Ristori, Silvia Romano, Stefania Cannoni, Carla Buttinelli, Giulia Coarelli, Nicola Vanacore, Carlo Pozzilli, Marco Salvetti · 2014 · Elsevier eBooks
  32. Quantitative T2′ imaging in patients with clinically isolated syndrome
    L. Y. Reitz, Matilde Inglese, Jens Fiehler, Jürgen Finsterbusch, Brigitte Holst, Christoph Heesen, Roland Martinꝉ, Sven Schippling · 2012 · Acta Neurologica Scandinavica
  33. Traitements de fond de la sclérose en plaques : enseignements des études randomisées comparatives directes
    Jean‐Christophe Ouallet · 2009 · Revue Neurologique
  34. Neue Einblicke in die Immunpathogenese der Multiplen Sklerose
    Berit Rosche, B. C. Kieseier, H.‐P. Hartung, Bernhard Hemmer · 2003 · Der Nervenarzt
  35. La part de l’inflammation dans la pathogénie de la sclérose en plaques
    Bruno Brochet · 2015 · Pratique Neurologique - FMC
  36. The challenges of measuring disability accumulation in relapsing–remitting multiple sclerosis: evidence from interferon beta treatments
    Bernd C. Kieseier · 2014 · Expert Review of Neurotherapeutics
  37. NEUROIMAGING OF DEMYELINATING DISEASES
    Istvan Pirko · 2008 · CONTINUUM Lifelong Learning in Neurology
  38. Review of the Clinical Debate Regarding Interventions for Multiple Sclerosis
    Melody Ann Ryan, Sara Deno, Howard Zwibel · 2009 · Journal of Managed Care Pharmacy
  39. Myelinating Proteins in MS Are Linked to Volumetric Brain MRI Changes
    Staley A. Brod, John A. Lincoln, Flavia M. Nelson · 2019 · Journal of Neuroimaging
  40. Continuous learning in multiple sclerosis care: a qualitative study of the expanded learning model for systems
    Dana Ravyn, Beth Goodwin, Rob Lowney · 2019 · International Journal of Medical Education
  41. Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue
    Biao Xiang, Jie Wen, Robert E. Schmidt, Alexander L. Sukstanskii, Daniel T. Mamah, Dmitriy A. Yablonskiy, Anne Haney Cross · 2022 · Annals of Clinical and Translational Neurology
  42. Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis
    Sara Llufriú, Eduardo Agüera, Lucienne Costa‐Frossard, Victoria Galán, Lamberto Landete, Daniel Lourido, Jose Eustasio Meca-Lallana, Esther Moral, Francisco A. Bravo-Rodríguez, L. Koren et al. · 2023 · Neurología (English Edition)
  43. Natural History of Multiple Sclerosis: When Do Axons Degenerate?
    David H. Miller · 2005 · Elsevier eBooks
  44. Optic Neuritis Revisited
    Fiona Costello · 2006 · International Journal of MS Care
  45. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
    Finn Thorup Sellebjerg · 2004 · PubMed
  46. Multiple Sclerosis; Diagnosis
    Robert Kang Shin · 2014 · Encyclopedia of the Neurological Sciences
  47. Multiple Sclerosis: Critical Review of the Evidence for each Question
    Graziella Filippini, George C. Ebers · 2007
  48. Multiple Sclerosis
    Dimitrios M. Karussis · 2016 · Elsevier eBooks
  49. Advances in the understanding and management of multiple sclerosis phenotypes
    Ali Msheik, Zeinab Al Mokdad, Reem Hmede, Rami Atat · 2025 · Health Sciences Review
  50. Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in Patients With Multiple Sclerosis
    Paolo Preziosa, Alessandro Meani, Nicolò Tedone, Irene Gattuso, Marco Rovaris, Maria Assunta Rocca, Massimo Filippi · 2026 · Neurology
  51. Comparison of Quality of Life in Clinically Isolated Syndrome Patients Who Convert and Do Not Convert to Clinically Definite Multiple Sclerosis
    Deborah M. Miller, Craig Kollman, Andrea Kalajian, Paul W O'Connor, R. Philip Kinkel · 2009 · International Journal of MS Care
  52. Prediction in treatment outcomes in multiple sclerosis: challenges and recent advances
    Deja R Rose, Moein Amin, Daniel Ontaneda · 2021 · Expert Review of Clinical Immunology
  53. Development of a predictive model for predicting disability after optic neuritis: a secondary analysis of the Optic Neuritis Treatment Trial
    Siqian Wei, Yi Du, Meifeng Luo, Ruitong Song · 2024 · Frontiers in Neurology
  54. Neurostimulation in Neuro-Ophthalmology: Mechanisms and Therapeutic Potential
    Nour Shaheen, M. Ben Khaled, Serah Seo, Yarema B. Bezchlibnyk, Oliver E. Flouty, Vishal Bharmauria · 2024 · IntechOpen eBooks
  55. Development and validation of a scoring system for predicting disease activity in treatment-naïve patients with relapsing-remitting multiple sclerosis
    Magd Fouad Zakaria, Nevin Shalaby, Farouk Talaat, Alaa N. Elmazny, Eman Hamdy, Mahmoud Saad Swelam, Mohamed Kamal, Mohamad Taha, Maged M. Abdel Naseer · 2025 · Multiple Sclerosis and Related Disorders
  56. Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis
    Sanuji. I. Gajamange, Jim M. Stankovich, Gary F. Egan, Trevor John Kilpatrick, Helmut Butzkueven, Joanne Fielding, Anneke van der Walt, Scott Kolbe · 2019 · Multiple Sclerosis Journal - Experimental Translational and Clinical
  57. Brain MRI findings in Japanese patients with clinically isolated syndrome
    Masami Tanaka, Rie Motoyama, Masayuki Tahara, Keiko Tanaka · 2012 · Rinsho Shinkeigaku
  58. Predicting Clinically Definite Multiple Sclerosis from Onset Using SVM
    PP Kwok, Olga Ciccarelli, Declan Chard, David H. Miller, Daniel C. Alexander · 2012 · Lecture notes in computer science
  59. Chapter 3 Natural History of Multiple Sclerosis
    2003 · Blue books of practical neurology
  60. MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No
    George C. Ebers · 2014 · Multiple Sclerosis Journal
  61. Early-Stage Multiple Sclerosis
    Per Soelberg Sørensen · 2004 · Drugs
  62. The Importance of Early Treatment
    Amy Perrin Ross · 2009 · Journal of Neuroscience Nursing
  63. Actualités thérapeutiques de la sclérose en plaques
    Olivier Gout, Caroline Bensa, Rana Assouad · 2010 · La Revue de Médecine Interne
  64. Antimyelin antibodies as predictors of disability after clinically isolated syndrome
    Oliver Findling, Isabelle Durot, Anja Weck, Simon Jung, Christian P. Kamm, Isabell Greeve, Heinrich Paul Mattle, Johann Sellner · 2013 · International Journal of Neuroscience
  65. Optic Neuritis and Multiple Sclerosis
    Edward J. Atkins, Valérie Biousse, Nancy J. Newman · 2007 · Springer eBooks
  66. Diagnosing Multiple Sclerosis and Its Imitators
    James D. Bowen · 2005 · Physical Medicine and Rehabilitation Clinics of North America
  67. Interferon-β1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis
    R. Philip Kinkel · 2006 · Expert Review of Clinical Immunology
  68. Immunotherapy of multiple sclerosis
    Sven Guenther Meuth, Stefan Bittner, Heinz Wiendl · 2009 · Acta Neuropsychiatrica
  69. Magnetresonanztomografie bei Patienten mit Multipler Sklerose: Relevanz in der Diagnose und Verlaufsbeurteilung
    Carsten Lukas, Michael Sailer · 2015 · Fortschritte der Neurologie · Psychiatrie
  70. Inflammatory optic neuritis
    Teresa Ayuso, D. Aliseda, Irache Ajuria, B. Zandío, Mayor, S., M.C. Navarro · 2009 · Anales del Sistema Sanitario de Navarra
  71. MRI Visualization of Multiple Sclerosis
    A. Cifelli, D. Arnold, P. Matthews · 2004 · Elsevier eBooks
  72. The optic nerve: a clinical perspective
    Pasquale Montaleone, Robin Deans · 2011
  73. Multiple Skleroz’lu Hastalarda Üst Ekstremite Ataksisinin Bilgisayar Analizi İle Değerlendirilmesi
    Fatma Erdeo, Kadriye Armutlu, Ali Ulvi Uca, İbrahim Yıldız · 2017 · Dicle Medical Journal / Dicle Tip Dergisi
  74. Evidence and Hyperbaric Oxygen Therapy
    Michael H Bennett, Robert J. Turner, Jan P Lehm, Herbert B. Newton · 2008 · Elsevier eBooks
  75. The physiopathology of multiple sclerosis
    Giancarlo Comi · 2010 · Cambridge University Press eBooks
  76. Developmental Disorders of the Nervous System
    Harvey B. Sarnat, Laura Flores‐Sarnat · 2012 · Elsevier eBooks
  77. Therapeutic Decision Making in Multiple Sclerosis: Best Practice Algorithms for the MS Care Clinician
    2014 · International Journal of MS Care
  78. Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease
    Andrew J. Walsh, Gregg Blevins, R. Marc Lebel, Peter Seres, Derek J. Emery, Alan H. Wilman · 2013 · Radiology
  79. MS: Clinical Features, Symptom Management, and Diagnosis
    J. Stankiewicz, G. Buckle · 2011 · Humana Press eBooks
  80. Measures of magnetization transfer
    Massimo Filippi, Joseph C. McGowan, Maria Assunta Rocca · 2011 · Cambridge University Press eBooks
  81. Importance of age at diagnosis in multiple sclerosis
    Jose Carlos Alvarez-Cermeño, Lucienne Costa‐Frossard, Luisa María Villar · 2010 · Expert Review of Neurotherapeutics
  82. Predicting Clinical Course
    Brian C. Healy, Maria Liguori · 2012
  83. Axons and Neurons in Corona Virus-Induced Demyelination
    Ajai A. Dandekar, Stanley M. Perlman · 2005 · Springer eBooks
  84. Therapy in clinical practice
    Jeffrey A. Cohen, Richard A. Rudick · 2011 · Cambridge University Press eBooks
  85. Basic mechanisms
    Jürg Kesselring, Gıancarlo Comı, Alan J. Thompson · 2010 · Cambridge University Press eBooks
  86. Advances in Multiple Sclerosis Imaging
    Istvan Pirko · 2009 · Blue books of neurology
  87. Multiple Sclerosis: An Emergency Medicine-Focused Narrative Review
    Jessica Pelletier, Davis Sugar, Alex Koyfman, Brit Long · 2023 · Journal of Emergency Medicine
  88. Prévenir la sclérose en plaques : un objectif réaliste ?
    Sandra Vukusic · 2012 · Revue Neurologique
  89. Sobre Esclerosis Múltiple, a propósito de un caso
    Romero Roberto, Rivera Pilar, Castro André · 2004 · Ciencia e Investigación Medico Estudiantil Latinoamericana
  90. Multiple sclerosis: diagnosis and definitions
    Anthony Feinstein · 2007 · Cambridge University Press eBooks
  91. Multiple Sclerosis
    Richard A. Rudick, Elizabeth Fisher, Gary Cutter · 2012 · Cambridge University Press eBooks
  92. Die Wertigkeit der evozierten Potenziale in der Diagnostik der multiplen Sklerose
    Thomas Haarmeier, JOHANNES DICHGANS · 2005 · Springer eBooks
  93. Disease modification in multiple sclerosis: Issues with relevance to clinical trial designs in Alzheimer's disease
    Richard A. Rudick · 2006 · Alzheimer s & Dementia
  94. Protocolo diagnóstico del paciente con sospecha de enfermedad desmielinizante
    Francisco Padilla Parrado, E. Salinas Íñigo · 2015 · Medicine - Programa de Formación Médica Continuada Acreditado
  95. Is TOPIC the last trial for clinically isolated syndrome?
    Bruce Cree · 2014 · Nature Reviews Neurology
  96. The Efficacy of Interferon Beta in Delaying Conversion to Clinically Definite Multiple Sclerosis
    Marcelo Kremenchutzky, R. Philip Kinkel · 2010 · International Journal of MS Care
  97. Three-dimensional brain magnetic resonance imaging segmentation via knowledge-driven decision theory
    Nishant Verma, Gautam S. Muralidhar, Alan Conrad Bovik, Matthew C. Cowperthwaite, Mark G. Burnett, Mia K. Markey · 2014 · Journal of medical imaging
  98. MRI for monitoring response to preventive treatment in multiple sclerosis
    Carlo Pozzilli, Nikolaos Petsas, Luca Prosperini · 2009 · Expert Review of Neurotherapeutics
  99. MEDICAL MANAGEMENT AND PHARMACOLOGY UPDATE
    Joel Brian Epstein, Judith E. Raber‐Durlacher, Maria-Gabriella Chavarria, Han Myint · 2009
  100. Computational Analysis of Brain MRI for Diagnosis and Monitoring of Multiple Sclerosis
    André Avelino, Meneses da Silva · 2014